Academics
Admissions
Hunter College Schools
Description: |
Discussion Questions: 1. Should the US introduce some form of price regulation for medicines? If so, how? 2. Intellectual property protections - mainly in the form of patents - are supposed to create incentives for innovation - including drug development. How well do you think this is working? Are there any possible alternatives to the current model? Readings: a. Scannell J. Four Reasons Drugs Are Expensive, Of Which Two Are False. Forbes.com October 13, 2015. https://www.forbes.com/sites/matthewherper/2015/10/13/four-reasons-drugs-are-expensive-of-which-two-are-false/#767128974c3b b. Light D, Lexchin J. Foreign free riders and the high price of US medicines BMJ 2005:331:958-60. http://www.bmj.com/content/331/7522/958.full.pdf c. Schrag D. The Price Tag on Progress — Chemotherapy for Colorectal Cancer. N Engl J Med 2004;351(4):317-319. http://www.nejm.org/doi/pdf/10.1056/NEJMp048143 d. Lakdawalla DN,Goldman DP,Michaud PC, Sood N. US Pharmaceutical Policy In A Global Marketplace. Health Affairs 2009;28(1):w138- w150. http://content.healthaffairs.org/content/28/1/w138.long |
Category: | Pre-Professional Advising |
Contact Email: | prehealth@hunter.cuny.edu |
Begins: | 03 Nov 2017 01:00 PM ET |
Ends: | 03 Nov 2017 02:30 PM ET |
Location: | Hunter East 710 |
Address: |
7th floor East building (by the bridge) Pre-Professional Advising Center Conference room |
Additional Details: | |
Status: | This event has passed. |
Please view the Anthology Privacy Policy to learn more about our policies and practices regarding the use and disclosure of the personal information you provide.